Out-Licensing Agreements - Contract Assets and Liabilities (Details) $ in Thousands |
9 Months Ended |
|---|---|
|
Sep. 30, 2024
USD ($)
| |
| Contract Liabilities: | |
| Balance at Beginning of Period | $ 11,954 |
| Balance at End of Period | 11,811 |
| Collaboration Agreements | |
| Contract Liabilities: | |
| Balance at Beginning of Period | 12,261 |
| Additions | 5,000 |
| Revenue Recognized | (5,450) |
| Balance at End of Period | 11,811 |
| Territory License - Rilonacept | |
| Contract Liabilities: | |
| Balance at Beginning of Period | 12,000 |
| Revenue Recognized | (189) |
| Balance at End of Period | 11,811 |
| Worldwide License - Vixarelimab | |
| Contract Liabilities: | |
| Balance at Beginning of Period | 261 |
| Additions | 5,000 |
| Revenue Recognized | $ (5,261) |